773 related articles for article (PubMed ID: 34019090)
1. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
Anton-Vazquez V; Clivillé R
Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
[No Abstract] [Full Text] [Related]
3. Some drugs for COVID-19.
Med Lett Drugs Ther; 2020 Apr; 62(1595):49-50. PubMed ID: 32324177
[No Abstract] [Full Text] [Related]
4. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
5. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
[TBL] [Abstract][Full Text] [Related]
6. Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement.
Best JH; Kong AM; Kaplan-Lewis E; Brawley OW; Baden R; Zazzali JL; Miller KS; Loveless J; Jariwala-Parikh K; Mohan SV
J Med Virol; 2021 Sep; 93(9):5367-5375. PubMed ID: 33913536
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.
Eleni M; Evangelia M; Eleftheria K; Vasilios V; Vana S; Vissaria S; Evangelos B; Ioannis K
Pathog Glob Health; 2021 Jun; 115(4):243-249. PubMed ID: 33645468
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
11. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
12. Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Quek E; Tahir H; Kumar P; Hastings R; Jha R
Br J Hosp Med (Lond); 2021 Mar; 82(3):1-9. PubMed ID: 33792391
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
[TBL] [Abstract][Full Text] [Related]
14. Audio Interview: Studying Potential Covid-19 Therapies.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
[No Abstract] [Full Text] [Related]
15. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
[TBL] [Abstract][Full Text] [Related]
18. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
19. Regulatory approval for COVID-19 across the globe.
Mahalmani V; Pugazhenthan T; Mittal N; Varthya SB; Medhi B
Indian J Pharmacol; 2020; 52(6):457-466. PubMed ID: 33666185
[No Abstract] [Full Text] [Related]
20. A metaresearch study revealed susceptibility of Covid-19 treatment research to white hat bias: first, do no harm.
Bellos I
J Clin Epidemiol; 2021 Aug; 136():55-63. PubMed ID: 33775812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
